O’rien, S.G., Guilhot, F., Goldman, J.M., et al. (2008) In-ternational Randomized Study of Interferon Reigns STl571 (IRIS) 7-Year Follow-Up: Sustained Survival, Low Rate of Transformation and Increased Rate of Major Molecular Response (MMR) in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib (IM). Blood, 112, abstr 186.